JP2024539126A5 - - Google Patents
Info
- Publication number
- JP2024539126A5 JP2024539126A5 JP2024523582A JP2024523582A JP2024539126A5 JP 2024539126 A5 JP2024539126 A5 JP 2024539126A5 JP 2024523582 A JP2024523582 A JP 2024523582A JP 2024523582 A JP2024523582 A JP 2024523582A JP 2024539126 A5 JP2024539126 A5 JP 2024539126A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- natural killer
- polynucleotide
- polynucleotide according
- killer cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163257608P | 2021-10-20 | 2021-10-20 | |
| US63/257,608 | 2021-10-20 | ||
| PCT/US2022/078331 WO2023069969A1 (en) | 2021-10-20 | 2022-10-19 | Engineering nk cells with a car construct with optimal signaling |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539126A JP2024539126A (ja) | 2024-10-28 |
| JP2024539126A5 true JP2024539126A5 (enExample) | 2025-10-15 |
Family
ID=86058649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523582A Pending JP2024539126A (ja) | 2021-10-20 | 2022-10-19 | 最適なシグナル伝達を有するｃａｒ構築物によるｎｋ細胞の操作 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240408203A1 (enExample) |
| EP (1) | EP4419128A4 (enExample) |
| JP (1) | JP2024539126A (enExample) |
| KR (1) | KR20240099309A (enExample) |
| CN (1) | CN118265535A (enExample) |
| AR (1) | AR127405A1 (enExample) |
| AU (1) | AU2022369294A1 (enExample) |
| CA (1) | CA3233096A1 (enExample) |
| CO (1) | CO2024002936A2 (enExample) |
| MX (1) | MX2024004772A (enExample) |
| TW (1) | TW202330586A (enExample) |
| WO (1) | WO2023069969A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121337979A (zh) * | 2025-04-03 | 2026-01-16 | 上海恩凯细胞技术有限公司 | 新型嵌合抗原受体修饰的免疫细胞及其在制备药物中的用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3668899A4 (en) * | 2017-08-18 | 2020-09-02 | Celdara Medical, LLC | CELL-BASED THERAPIES TARGETING DISEASE-ASSOCIATED MOLECULAR MEDIATORS OF FIBROTIC, INFLAMMATORY AND AUTOIMMUNE DISEASES |
| EP4031577A4 (en) * | 2019-09-18 | 2023-12-20 | Board of Regents, The University of Texas System | METHOD FOR ENGINEERING NATURAL KILLER CELLS TO TARGET BCMA-POSITIVE TUMORS |
| CA3216557A1 (en) * | 2021-04-14 | 2022-10-20 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors to target cd5-positive cancers |
| CA3221568A1 (en) * | 2021-05-26 | 2022-12-01 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor to target hla-g-positive cancers |
| WO2023283644A2 (en) * | 2021-07-09 | 2023-01-12 | Board Of Regents, The University Of Texas System | Chimeric antigen receptor to target trop-2-positive cancers |
-
2022
- 2022-10-19 EP EP22884661.4A patent/EP4419128A4/en active Pending
- 2022-10-19 AU AU2022369294A patent/AU2022369294A1/en active Pending
- 2022-10-19 CA CA3233096A patent/CA3233096A1/en active Pending
- 2022-10-19 MX MX2024004772A patent/MX2024004772A/es unknown
- 2022-10-19 TW TW111139574A patent/TW202330586A/zh unknown
- 2022-10-19 AR ARP220102843A patent/AR127405A1/es unknown
- 2022-10-19 CN CN202280076663.4A patent/CN118265535A/zh active Pending
- 2022-10-19 US US18/699,702 patent/US20240408203A1/en active Pending
- 2022-10-19 JP JP2024523582A patent/JP2024539126A/ja active Pending
- 2022-10-19 KR KR1020247016522A patent/KR20240099309A/ko active Pending
- 2022-10-19 WO PCT/US2022/078331 patent/WO2023069969A1/en not_active Ceased
-
2024
- 2024-03-11 CO CONC2024/0002936A patent/CO2024002936A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240041933A1 (en) | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof | |
| Bontkes et al. | Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells | |
| JP2024138280A5 (enExample) | ||
| Redeker et al. | Improving adoptive T cell therapy: the particular role of T cell costimulation, cytokines, and post-transfer vaccination | |
| CN106536563B (zh) | 嵌合抗原受体 | |
| JP2024527559A5 (enExample) | ||
| JP2021525534A5 (enExample) | ||
| JP2024514203A5 (enExample) | ||
| CN112055717A (zh) | 用在免疫细胞中表达的膜结合抗细胞因子非信号传导粘合剂中和人细胞因子 | |
| US12280092B2 (en) | Reprogrammed T cell-like NK cells | |
| CN106535925A (zh) | 基于car的免疫治疗 | |
| JP2024521185A5 (enExample) | ||
| JP2024525609A5 (enExample) | ||
| CN111918964A (zh) | 促进免疫细胞增殖的方法 | |
| JP2022548902A5 (enExample) | ||
| JP2024539126A5 (enExample) | ||
| WO2023150801A2 (en) | Recombinant proteins that stimulate an immune response in the presence of naturally inhibitory ligand binding | |
| Weinstein-Marom et al. | Combined expression of genetic adjuvants via mRNA electroporation exerts multiple immunostimulatory effects on antitumor T cells | |
| CN111499766B (zh) | 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用 | |
| JP6684211B2 (ja) | Ｂ細胞集団の製造方法 | |
| JP2022513099A5 (enExample) | ||
| US20250073268A1 (en) | Chimeric cd40 polypeptides and methods of use in immunotherapy | |
| RU2024113197A (ru) | Модифицирование nk-клеток конструкцией car с оптимальной передачей сигнала | |
| WO2025166113A1 (en) | Cell-free implants for in vivo recruitment, activation, and reprogramming of immune cells | |
| HK40100191A (zh) | 用於同种异体细胞治疗的通用嵌合抗原受体表达免疫细胞 |